Next Article in Journal
Immunity Profiling of COVID-19 Infection, Dynamic Variations of Lymphocyte Subsets, a Comparative Analysis on Four Different Groups
Next Article in Special Issue
Impact of Healthcare-Associated Infections Connected to Medical Devices—An Update
Previous Article in Journal
Seroprevalence Estimates of Latent and Acute Toxoplasma Infections in HIV+ People—Call for Action in Underprivileged Communities
Previous Article in Special Issue
Titanium Wear Particles Exacerbate S. epidermidis-Induced Implant-Related Osteolysis and Decrease Efficacy of Antibiotic Therapy
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Communication

Comparison of Two Cutibacterium acnes Biofilm Models

by
Jennifer Varin-Simon
1,
Fabien Lamret
1,
Marius Colin
1,2,
Sophie C. Gangloff
1,2,
Céline Mongaret
1,2,3,*,† and
Fany Reffuveille
1,2,*,†
1
EA 4691 Biomatériaux et Inflammation en Site Osseux (BIOS), Université de Reims Champagne-Ardenne, SFR Cap Santé (FED 4231), 51100 Reims, France
2
UFR Pharmacie, Université de Reims Champagne Ardenne, 51100 Reims, France
3
Service Pharmacie, Centre Hospitalier Universitaire de Reims, 51100 Reims, France
*
Authors to whom correspondence should be addressed.
Both authors contributed equally to the work.
Microorganisms 2021, 9(10), 2035; https://doi.org/10.3390/microorganisms9102035
Submission received: 30 August 2021 / Revised: 13 September 2021 / Accepted: 23 September 2021 / Published: 26 September 2021
(This article belongs to the Special Issue Biofilms and Device-Associated Infections)

Abstract

:
The study of biofilms in vitro is complex and often limited by technical problems due to simplified models. Here, we compared C. acnes biofilm formation, from species involved in bone and prosthesis infection, in a static model with a dynamic model. Using similar parameters, the percentage of live bacteria within the biofilm was higher in dynamic than in static approach. In both models, bacterial internalization in osteoblast-like cells, playing the role of stress factor, affected this proportion but in opposite ways: increase of live bacteria proportion in the static model (×2.04 ± 0.53) and of dead bacteria proportion (×3.5 ± 1.03) in the dynamic model. This work highlights the huge importance in the selection of a relevant biofilm model in accordance with the environmental or clinical context to effectively improve the understanding of biofilms and the development of better antibiofilm strategies.

1. Introduction

The need for joint prostheses is continuously increasing due to the aging of the population [1,2]. Unfortunately, even taking into account prophylaxis and aseptic surgical techniques, the risk of bone and joint infections does not decrease (approximately 1 to 2% of procedures) [3]. In the event of infection, the presence of a prosthesis allows bacteria to adhere to it, to develop a biofilm and to trigger an infection of the surrounding tissues. This bacterial ability to form a biofilm appears to be a very worrying threat. Resulting from strong social behavior, this microbial community is surrounded by a protective extracellular matrix [3,4,5,6] which is found to be the most effective defense against all types of antimicrobials and against attacks by the immune system [3]. The consequences of biofilm formation are the persistence of these microbial agents which leads to clinical symptoms linked to the inflammatory response such as fever and pain. These sequelae are often irreversible (loosening of prosthesis, amputation), and fatal in some cases. All clinical consequences represent high costs for society [1,7]. In such a clinical context, it becomes urgent to consider new strategies and develop new molecules to treat acute and chronic infections due to biofilms; this goes through a better description of biofilm mechanisms. The structure and composition of the biofilm depend on many parameters: the bacterial strains, the stage of development, the presence or absence of an antibiotic, and especially the microenvironment [8,9,10,11,12,13,14,15,16]. The biofilm will therefore be different depending on the environmental conditions (presence of oxygen, nutrients, and host cells) but also depending on the surface on which it is formed [17,18,19,20]. Thus the proportion of adhered bacteria, living or dead, and the matrix composition within biofilm are different according to the bacterial species and the infected site [21]. All these parameters should be taken in account in experiments.
In consequence, studying biofilm infections is complex, especially because of the limited in vitro models. Many authors agree on the need to jointly use miscellaneous methods to fully describe a biofilm: its structure, organization, and live and dead populations [22,23,24]. Classical crystal violet assay or microscopic visualization thanks to fluorescence dyes are usually used to define biofilm characterizations [25,26,27]. However, in 2019, 29 researchers with international expertise in biofilms came together to identify gaps in this area. The lack of relevant, standardized models adapted to in situ conditions was raised (Biofilm BASH 2019, [23]). Indeed, several publications have shown the huge influence of culture conditions on biofilm formation [28,29,30], but also the influence of the structure and composition of the surface on which the biofilm develops [31,32].
Cutibacterium acnes is an emerging anaerobic pathogen frequently involved in prosthetic joint infections. Potential inflammatory and virulent factors involved in adherence to skin tissue were identified among C. acnes components: A specific envelope with peptide chain containing L-acid L-diaminopelic acid and D-alanine, and polysaccharide moiety with an amino sugar thought to be a diamunihexuronic acid [33]; lipase leading to neutrophil chemotaxis [34]; other many various factors (neuraminidase, polyunsaturated fatty acid isomerase) and host-interacting factors, such as CAMP factors, hemolysins and dermatan sulphate-binding adhesins (DsA1 and DsA2) [35]. Virulent factors involved in biofilm formation were not clearly identified but adhesins are known to be involved in adhesion, which is the first step of biofilm formation. C. acnes infection is evaluated to account for 10% of BPIs but this is probably underestimated [36]. This infection is often delayed (occurring 3 to 24 months or more after prosthesis setting) [37]. The establishment of biofilms explains the complex pathogenesis of C. acnes-related BPI. This peculiar bacterial growth makes such chronic infections difficult to diagnose, to treat and to eradicate. In a previous study, several C. acnes strains were co-cultured with osteoblast-like cells in order to highlight the impact of the bacterial internalization into the host cells on the biofilm formation of C. acnes [38]. We used a static model in microtiter plates, in which biofilm biomass was stained with crystal violet or labelled with fluorochrome markers to quantify live and dead bacteria proportions. However, we were limited for 3D structure observation due to our technical approach. Indeed, the biofilm formed in the microtiter plate was not observable under confocal microscopy due to incompatibility between the focal distance and plastic thickness.
In this study, we hereby used a dynamic flow cell channels model to apprehend confocal microscopic observation using an adapted three-channel flow-cell chamber. Obvious differences appear between the static model and the present dynamic model: the force due to shear flow leading to a physical pressure on biofilm formation, a permanent circulation of nutrients and a variability of oxygen level due to the technic of the flow experiment. In this communication, the differences resulting from both models will be described and compared to underline the importance of choosing the suitable biofilm model to correlate with the conditions of the infectious site studied.

2. Methods

2.1. Bacteria and Culture

Cutibacterium acnes (formerly Propionibacterium acnes) strains were isolated at the laboratory of bacteriology of Reims University hospital (CHU Reims). Strains were identified by mass spectrophotometry in routine by University hospital. Four clinical isolates were non-infection related strains (C2, C5, C8, and C18) and after being anonymized, these strains were labeled as infection-naive strains. Nine other C. acnes strains were isolated from bone and prosthesis infections BPIs (BPI 1 to BPI 9). They were defined when at least three of the five samples from the bone and joint tissue during orthopedic surgery were positive. C. acnes strains were isolated on Columbia agar with 5% sheep blood (BioRad, Hercules, CA, USA) and cultivated in a Brain Heart Infusion (BHI) broth (BioRad, Hercules, CA, USA) for five days under anaerobic conditions using the GenBox system (Biomerieux, Marcy l’Etoile, France) at 37 °C.

2.2. Flow Cells Models and Microscopy

In this dynamic model, C. acnes biofilms were grown for 96 h at 37 °C in flow chambers (IBI Scientific, Dubuque, Iowa, USA). The system was assembled and sterilized by pumping a 0.2% hypochlorite solution through the system for 2 h using a peristaltic pump. The system was rinsed with sterile water and then by diluted medium (BHI diluted 1/10e with sterile water) for 1 h with a rate of 20 mL/h. Flow chambers were inoculated by injecting a 5-day-old bacterial culture diluted at 1/20. Inoculated chambers were flipped upside-down, without flow for 3 h to let bacteria adhere. Then, fresh diluted medium was pumped through the system at a constant rate of 0.2 mL/h during four days. The flow cells model was detailed in Figure 1. After 96 h, biofilms were stained using the Live/Dead BacLight bacterial viability kit (Molecular probes) at a ratio 1:5 of Syto-9 to propidium iodide. Biofilms were observed using a LMS 710 NLO confocal laser scanning microscope (Zeiss), and two joined fields were captured. The observation of the biofilm was carried out twice for the strains C2, C5, C8, and C18 after internalization and once for the other experiments. The homogeneity of the samples was checked by traversing the observation field and the most representative area was chosen for the acquisition of the image. Three-dimensional reconstructions and fluorescents volumes were generated using Imaris software.

3. Results and Discussion

Based on our previous results [38], after testing seven commensal C. acnes strains, four were selected for their capacity to increase biofilm formation after their internalization in osteoblast-like cells to perform our experimentations. This change in their biofilm capacity served as a “landmark” element for comparison between static and dynamic models. Thus, we evaluated a dynamic flow model (Figure 1), which couples the use of flow cells and confocal microscopy to appreciate the structure and organization of biofilm (Figure 2a).
The four strains presented biofilms of equal volume (Figure 2b), however, differences should be noted. The C2 and C5 strains formed a thick monolayer biofilm, which was highly homogeneous, however, with aggregates more present in C5 isolate. Strain C8 also formed a monolayer biofilm but the aggregates were more dispersed, and biofilm appeared thinner. C18 strain formed a biofilm, which was completely different with large and very thick aggregates. Between these “mushroom”-type formations often described in other species, we observed a monolayer biofilm but shaped by as many dead bacteria as living. Thus, this revealed organizational differences between strains, with thick monolayer biofilm (C2, C5, C8) or the presence of larger aggregates and different proportion of dead bacteria (C18).
For different purposes, we evaluated the proportion of living and dead bacteria (Figure 2c) within biofilm. First, if the biofilm is mainly composed of living bacteria, these are cells that might be released much later and therefore induce new contaminations on other sites [3]. The second reason is that the quantity of dead bacteria can also release DNA after lysis, which participates in matrix formation and therefore the resistance of the biofilm [3]. C2, C5, and C8 strains formed a biofilm whose composition in living bacteria was very similar, close to 90%. Only the C18 strain had a lower proportion with 70% live bacteria. This could be explained by the presence of large aggregates which could lead to bacteria death [39]. From a global point of view, the percentage of living bacteria within biofilm was higher in the dynamic than in the static model with the exception of C18 strains; with an average of 88.5% (±1%) for C2, C5, and C8 vs. an average of 56.8% (±9%) in the static model (data from reference [38]).
We compared biofilm structures of C2, C5, C8, and C18 after osteoblast infection in our dynamic model. They were similar to those formed before internalization for C5 and C8, but there were different for C2 and C18 (Figure 3a). Biofilm volumes were on average 1.5 times smaller after internalization than before (Figure 3b) except for C8. However, the C2 and C18 strains formed the most diminished biofilms with an almost three-fold decrease. Following the internalization, an increase in the proportion of dead bacteria was observed for all strains except for C18 in the dynamic model (Figure 3c). Biofilms formed in the dynamic model by the C5, C8, and C18 strains showed a rate of living bacteria around 80 ± 20%. We observed a heterogeneous distribution of C2 bacteria within biofilm with aggregates and also bacteria free-areas. The C2 strain showed a 50% loss of total biofilm volume after internalization (Figure 3b); however, there was a three-fold decrease of living bacteria volume and a 1.8-fold increase of dead bacteria volume. However, the rates were very variable, with a living bacteria proportion around 56 ± 40%. We noted that some aggregates were only composed of dead bacteria. We noticed an increase in biomass for C8 strain (Figure 3b) with a strong increase in dead bacteria proportion (×3) (Figure 3c). A similar behavior was observed for the C5 strain (20% loss of total biofilm with 2.3-fold increase of dead bacteria volume). Concerning the C18 strain, we evaluated a biomass decrease in equivalent proportions for live and dead bacteria (60–70% decrease). Unlike before internalization, we did not see any important mushroom-like structures for C18, neither a monolayer composed of an equal proportion of live and dead bacteria but a simple monolayer biofilm with some dead bacteria, similar to a C8 biofilm structure. All these results combined highlighted the important differences between C. acnes strains in terms of biofilm responses following internalization.
These data were compared to results previously obtained in a static model [38] to assess the modification of live/dead bacteria proportions after internalization in the two tested models. Even if the internalization of the four selected commensal strains (C2, C5, C8, and C18) had an impact in the biofilm formation through both models, the results clearly were in opposition. Indeed, our previous publication using the static model demonstrated an increase of live bacteria proportion of the four commensal C. acnes biofilm after internalization (×2.04 ± 0.53 in average). In the current dynamic model, we observed no important change except an increase in dead bacteria proportion for C2 strain (×4), and no volume expansion.
The explanation of the opposite results about live and dead biofilm proportion in the two models was the presence of variable conditions (oxygen and nutrient concentrations) as described above. Moreover, in static model, the dispersed bacteria remained close to biofilm whereas in dynamic models, dispersed bacteria were eventually carried away by the flow. The data presented here confirmed that all variations in biofilm condition culture will affect the results of a study [24]. In a bone context, such a flow and oxygen are limited, unlike infections on heart valves for example, underlining that a dynamic model to study biofilm in on prosthesis and joint infection context may not be as relevant as a static model.
To complete this approach, we also observed the biofilm formation of nine clinical strains isolated from bone and prosthesis infections (BPI). Biofilms formed in a dynamic model presented very heterogeneous structures (Figure 4). BPI strains 1, 5, 7, 8, and 9 developed very thick biofilms, the last three of which have very large aggregates, resembling the mushroom-type form and emphasizing a certain biofilm maturity (Figure 4a,b).
On average, BPI biofilms in flow cells models had a total volume of 2.8 × 106 ± 0.6 UA while the commensal strains were on average twice as small (1.3 × 106 ± 0.4 UA). However, some strains, such as BPI 2 or BPI4, showed a very fine biofilm, with only a few aggregates. In our previous publication [38], we have observed that BPI biofilms were more important than commensal ones before internalization. In this case, our results were concordant. Concerning the live/dead proportion, BPI biofilms in dynamic models were composed of 69 to 97% of live bacteria with an average of 89.5 ± 2.7% (Figure 4c), which is higher than in static models (61.2%) [38]. Again, the proportion of live bacteria was different in the two models confirming that permanent supply of a “fresh” medium with nutrients and oxygen in the flow cell model should allow better survival of bacteria within biofilm. To verify this hypothesis, we will have to repeat experiments in controlling these parameters.

4. Conclusions

In conclusion, in a bone and prosthesis infection context, liquid flow and oxygen are limited; therefore, a dynamic model to study C. acnes biofilm may not be as relevant as a static model. All these results underline the importance of the model choice for investigations on biofilm [23,24,40]. First, the medium in which biofilm is formed. In bone context, we described many different factors that could influence bacteria: lack of oxygen, nutrient starvation, excess of magnesium, and secretome of active bone cells [28]. Second, the presence of various types of surfaces will also affect bacteria attachment: bone surface, host matrix, and prosthesis implant, which is titanium most of the time [3]. For example, C. acnes biofilm is boosted on titanium surface [38].
There is an urgent need of in vitro biofilm model adapted to the clinical context to better understand mechanisms of biofilm infection to target specific biofilm characteristic but also to enhance antibiofilm molecules screening. Without consensus of in vitro biofilm models, in vivo biofilms remain the most representative methods to mimic infections in clinical context [41] especially in BPIs, where it is quite expensive.

Author Contributions

Conceptualization, C.M. and F.R.; methodology, J.V.-S. and F.L.; software, J.V.-S. validation, M.C., C.M. and F.R.; formal analysis, J.V.-S.; investigation, C.M. and F.R.; resources, C.M. and F.R.; data curation, J.V.-S.; writing—original draft preparation, M.C., C.M. and F.R.; writing—review and editing, M.C., S.C.G., C.M. and F.R.; visualization C.M. and F.R.; supervision, C.M. and F.R.; project administration, S.C.G., C.M. and F.R.; funding acquisition, S.C.G., C.M. and F.R. All authors have read and agreed to the published version of the manuscript.

Funding

This research received funding from AOL Reims Hospital Funding, URCA Fundation, COSIBIOOS Grand Est fundings.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

Not applicable.

Acknowledgments

Authors acknowledge Véronique Vernet-Garnier for providing C. acnes strains.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Tande, A.J.; Patel, R. Prosthetic joint infection. Clin. Microbiol. Rev. 2014, 27, 302–345. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  2. Kurtz, S.; Ong, K.; Lau, E.; Mowat, F.; Halpern, M. Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030. J. Bone Jt. Surg. Am. 2007, 89, 780–785. [Google Scholar] [CrossRef]
  3. Lamret, F.; Colin, M.; Mongaret, C.; Gangloff, S.C.; Reffuveille, F. Antibiotic Tolerance of Staphylococcus aureus Biofilm in Periprosthetic Joint Infections and Antibiofilm Strategies. Antibiotics 2020, 9, 547. [Google Scholar] [CrossRef] [PubMed]
  4. de la Fuente-Núñez, C.; Reffuveille, F.; Fernández, L.; Hancock, R.E.W. Bacterial biofilm development as a multicellular adaptation: Antibiotic resistance and new therapeutic strategies. Curr. Opin. Microbiol. 2013, 16, 580–589. [Google Scholar] [CrossRef]
  5. Hall, C.W.; Mah, T.-F. Molecular mechanisms of biofilm-based antibiotic resistance and tolerance in pathogenic bacteria. FEMS Microbiol. Rev. 2017, 41, 276–301. [Google Scholar] [CrossRef] [PubMed]
  6. Reffuveille, F.; Josse, J.; Vallé, Q.; Gangloff, C.M.; Gangloff, S.C. Staphylococcus aureus Biofilms and their Impact on the Medical Field. In The Rise of Virulence and Antibiotic Resistance in Staphylococcus Aureus; BoD–Books on Demand: Norderstedt, Germany, 2017. [Google Scholar]
  7. Josse, J.; Valour, F.; Maali, Y.; Diot, A.; Batailler, C.; Ferry, T.; Laurent, F. Interaction Between Staphylococcal Biofilm and Bone: How Does the Presence of Biofilm Promote Prosthesis Loosening? Front. Microbiol. 2019, 10, 1602. [Google Scholar] [CrossRef]
  8. Tasse, J.; Trouillet-Assant, S.; Josse, J.; Martins-Simões, P.; Valour, F.; Langlois-Jacques, C.; Badel-Berchoux, S.; Provot, C.; Bernardi, T.; Ferry, T.; et al. Association between biofilm formation phenotype and clonal lineage in Staphylococcus aureus strains from bone and joint infections. PLoS ONE 2018, 13, e0200064. [Google Scholar] [CrossRef] [Green Version]
  9. Moormeier, D.E.; Bose, J.L.; Horswill, A.R.; Bayles, K.W. Temporal and stochastic control of Staphylococcus aureus biofilm development. mBio 2014, 5, e01341-14. [Google Scholar] [CrossRef] [Green Version]
  10. McCarthy, H.; Rudkin, J.K.; Black, N.S.; Gallagher, L.; O’Neill, E.; O’Gara, J.P. Methicillin resistance and the biofilm phenotype in Staphylococcus aureus. Front. Cell Infect. Microbiol. 2015, 5, 1. [Google Scholar] [CrossRef] [Green Version]
  11. Fitzpatrick, F.; Humphreys, H.; O’Gara, J.P. The genetics of staphylococcal biofilm formation--will a greater understanding of pathogenesis lead to better management of device-related infection? Clin. Microbiol. Infect. 2005, 11, 967–973. [Google Scholar] [CrossRef] [Green Version]
  12. O’Neill, E.; Pozzi, C.; Houston, P.; Smyth, D.; Humphreys, H.; Robinson, D.A.; O’Gara, J.P. Association between methicillin susceptibility and biofilm regulation in Staphylococcus aureus isolates from device-related infections. J. Clin. Microbiol. 2007, 45, 1379–1388. [Google Scholar] [CrossRef] [Green Version]
  13. Rohde, H.; Burandt, E.C.; Siemssen, N.; Frommelt, L.; Burdelski, C.; Wurster, S.; Scherpe, S.; Davies, A.P.; Harris, L.G.; Horstkotte, M.A.; et al. Polysaccharide intercellular adhesin or protein factors in biofilm accumulation of Staphylococcus epidermidis and Staphylococcus aureus isolated from prosthetic hip and knee joint infections. Biomaterials 2007, 28, 1711–1720. [Google Scholar] [CrossRef]
  14. Boles, B.R.; Thoendel, M.; Roth, A.J.; Horswill, A.R. Identification of genes involved in polysaccharide-independent Staphylococcus aureus biofilm formation. PLoS ONE 2010, 5, e10146. [Google Scholar] [CrossRef] [Green Version]
  15. Brooks, J.L.; Jefferson, K.K. Phase variation of poly-N-acetylglucosamine expression in Staphylococcus aureus. PLoS Pathog. 2014, 10, e1004292. [Google Scholar] [CrossRef]
  16. Moormeier, D.E.; Bayles, K.W. Staphylococcus aureus biofilm: A complex developmental organism. Mol. Microbiol. 2017, 104, 365–376. [Google Scholar] [CrossRef] [Green Version]
  17. Bjarnsholt, T.; Ciofu, O.; Molin, S.; Givskov, M.; Høiby, N. Applying insights from biofilm biology to drug development—Can a new approach be developed? Nat. Rev. Drug Discov. 2013, 12, 791–808. [Google Scholar] [CrossRef]
  18. Haney, E.F.; Brito-Sánchez, Y.; Trimble, M.J.; Mansour, S.C.; Cherkasov, A.; Hancock, R.E.W. Computer-aided Discovery of Peptides that Specifically Attack Bacterial Biofilms. Sci. Rep. 2018, 8, 1871. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  19. Feng, J.; de la Fuente-Núñez, C.; Trimble, M.J.; Xu, J.; Hancock, R.E.W.; Lu, X. An in situ Raman spectroscopy-based microfluidic “lab-on-a-chip” platform for non-destructive and continuous characterization of Pseudomonas aeruginosa biofilms. Chem. Commun. 2015, 51, 8966–8969. [Google Scholar] [CrossRef] [PubMed]
  20. Forson, A.M.; van der Mei, H.C.; Sjollema, J. Impact of solid surface hydrophobicity and micrococcal nuclease production on Staphylococcus aureus Newman biofilms. Sci. Rep. 2020, 10, 12093. [Google Scholar] [CrossRef] [PubMed]
  21. Barrila, J.; Crabbé, A.; Yang, J.; Franco, K.; Nydam, S.D.; Forsyth, R.J.; Davis, R.R.; Gangaraju, S.; Ott, C.M.; Coyne, C.B.; et al. Modeling Host-Pathogen Interactions in the Context of the Microenvironment: Three-Dimensional Cell Culture Comes of Age. Infect. Immun. 2018, 86, e00282-18. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  22. Haney, E.F.; Mansour, S.C.; Hilchie, A.L.; de la Fuente-Núñez, C.; Hancock, R.E.W. High throughput screening methods for assessing antibiofilm and immunomodulatory activities of synthetic peptides. Peptides 2015, 71, 276–285. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  23. Coenye, T.; Kjellerup, B.; Stoodley, P.; Bjarnsholt, T. 2019 Biofilm Bash Participants The future of biofilm research—Report on the “2019 Biofilm Bash”. Biofilm 2020, 2, 100012. [Google Scholar] [CrossRef] [PubMed]
  24. Muthukrishnan, G.; Masters, E.A.; Daiss, J.L.; Schwarz, E.M. Mechanisms of Immune Evasion and Bone Tissue Colonization That Make Staphylococcus aureus the Primary Pathogen in Osteomyelitis. Curr. Osteoporos. Rep. 2019, 17, 395–404. [Google Scholar] [CrossRef]
  25. Coenye, T.; Peeters, E.; Nelis, H.J. Biofilm formation by Propionibacterium acnes is associated with increased resistance to antimicrobial agents and increased production of putative virulence factors. Res. Microbiol. 2007, 158, 386–392. [Google Scholar] [CrossRef] [Green Version]
  26. Holmberg, A.; Lood, R.; Mörgelin, M.; Söderquist, B.; Holst, E.; Collin, M.; Christensson, B.; Rasmussen, M. Biofilm formation by Propionibacterium acnes is a characteristic of invasive isolates. Clin. Microbiol. Infect. 2009, 15, 787–795. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  27. Seper, A.; Pressler, K.; Kariisa, A.; Haid, A.G.; Roier, S.; Leitner, D.R.; Reidl, J.; Tamayo, R.; Schild, S. Identification of genes induced in Vibrio cholerae in a dynamic biofilm system. Int. J. Med. Microbiol. 2014, 304, 749–763. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  28. Reffuveille, F.; Josse, J.; Velard, F.; Lamret, F.; Varin-Simon, J.; Dubus, M.; Haney, E.F.; Hancock, R.E.W.; Mongaret, C.; Gangloff, S.C. Bone Environment Influences Irreversible Adhesion of a Methicillin-Susceptible Staphylococcus aureus Strain. Front. Microbiol. 2018, 9, 2865. [Google Scholar] [CrossRef] [Green Version]
  29. Crabbé, A.; Jensen, P.Ø.; Bjarnsholt, T.; Coenye, T. Antimicrobial Tolerance and Metabolic Adaptations in Microbial Biofilms. Trends Microbiol. 2019, 27, 850–863. [Google Scholar] [CrossRef]
  30. Mashruwala, A.A.; van de Guchte, A.; Boyd, J.M. Impaired respiration elicits SrrAB-dependent programmed cell lysis and biofilm formation in Staphylococcus aureus. eLife 2017, 6, e23845. [Google Scholar] [CrossRef]
  31. Bidossi, A.; Bottagisio, M.; De Grandi, R.; De Vecchi, E. Ability of adhesion and biofilm formation of pathogens of periprosthetic joint infections on titanium-niobium nitride (TiNbN) ceramic coatings. J. Orthop. Surg. Res. 2020, 15, 90. [Google Scholar] [CrossRef] [Green Version]
  32. Oliveira, W.F.; Silva, P.M.S.; Silva, R.C.S.; Silva, G.M.M.; Machado, G.; Coelho, L.C.B.B.; Correia, M.T.S. Staphylococcus aureus and Staphylococcus epidermidis infections on implants. J. Hosp. Infect. 2018, 98, 111–117. [Google Scholar] [CrossRef]
  33. Whale, G.A.; Sutcliffe, I.C.; Morrisson, A.R.; Pretswell, E.L.; Emmison, N. Purification and characterisation of lipoglycan macroamphiphiles from Propionibacterium acnes. Antonie Van Leeuwenhoek 2004, 86, 77–85. [Google Scholar] [CrossRef]
  34. Lee, W.L.; Shalita, A.R.; Suntharalingam, K.; Fikrig, S.M. Neutrophil chemotaxis by Propionibacterium acnes lipase and its inhibition. Infect. Immun. 1982, 35, 71–78. [Google Scholar] [CrossRef] [Green Version]
  35. Dréno, B.; Pécastaings, S.; Corvec, S.; Veraldi, S.; Khammari, A.; Roques, C. Cutibacterium acnes (Propionibacterium acnes) and acne vulgaris: A brief look at the latest updates. J. Eur. Acad. Dermatol. Venereol. 2018, 32, 5–14. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  36. Aubin, G.G.; Lavigne, J.-P.; Foucher, Y.; Dellière, S.; Lepelletier, D.; Gouin, F.; Corvec, S. Tropism and virulence of Cutibacterium (formerly Propionibacterium) acnes involved in implant-associated infection. Anaerobe 2017, 47, 73–78. [Google Scholar] [CrossRef] [PubMed]
  37. Portillo, M.E.; Corvec, S.; Borens, O.; Trampuz, A. Propionibacterium acnes: An underestimated pathogen in implant-associated infections. BioMed Res. Int. 2013, 2013, 804391. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  38. Mongaret, C.; Varin-Simon, J.; Lamret, F.; El-Mahdy, T.S.; Brasme, L.; Vernet-Garnier, V.; Gangloff, S.C.; Ohl, X.; Reffuveille, F. Cutibacterium acnes Biofilm Study during Bone Cells Interaction. Microorganisms 2020, 8, 1409. [Google Scholar] [CrossRef] [PubMed]
  39. Allocati, N.; Masulli, M.; Di Ilio, C.; De Laurenzi, V. Die for the community: An overview of programmed cell death in bacteria. Cell Death Dis. 2015, 6, e1609. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  40. Haney, E.F.; Trimble, M.J.; Cheng, J.T.; Vallé, Q.; Hancock, R.E.W. Critical Assessment of Methods to Quantify Biofilm Growth and Evaluate Antibiofilm Activity of Host Defence Peptides. Biomolecules 2018, 8, 29. [Google Scholar] [CrossRef] [Green Version]
  41. Nishitani, K.; Sutipornpalangkul, W.; de Mesy Bentley, K.L.; Varrone, J.J.; Bello-Irizarry, S.N.; Ito, H.; Matsuda, S.; Kates, S.L.; Daiss, J.L.; Schwarz, E.M. Quantifying the natural history of biofilm formation in vivo during the establishment of chronic implant-associated Staphylococcus aureus osteomyelitis in mice to identify critical pathogen and host factors. J. Orthop. Res. 2015, 33, 1311–1319. [Google Scholar] [CrossRef] [Green Version]
Figure 1. Flow cells model of Cutibacterium acnes biofilm.
Figure 1. Flow cells model of Cutibacterium acnes biofilm.
Microorganisms 09 02035 g001
Figure 2. C. acnes biofilms in dynamic model. (a) Biofilm structure of commensal C. acnes strains marked with Syto9 (green) and PI (red) fluorochromes; (b) volume of biofilm biomass with repartition of Syto9 and PI staining; (c) repartition of Syto9 and PI staining in percentage (Acquisition of images by fluorescent microscopy of two joined fields of one sample and calculation by Imaris software). Scale = 100 µm.
Figure 2. C. acnes biofilms in dynamic model. (a) Biofilm structure of commensal C. acnes strains marked with Syto9 (green) and PI (red) fluorochromes; (b) volume of biofilm biomass with repartition of Syto9 and PI staining; (c) repartition of Syto9 and PI staining in percentage (Acquisition of images by fluorescent microscopy of two joined fields of one sample and calculation by Imaris software). Scale = 100 µm.
Microorganisms 09 02035 g002
Figure 3. C. acnes biofilms after osteoblast-like internalization (a) Biofilm structure of commensal C. acnes strains in dynamic model; (b) volume of biofilm biomass with repartition of Syto9 and PI staining; (c) repartition of Syto9 and PI staining in percentage (Acquisition of images by fluorescent microscopy of two joined fields of one sample and calculation by Imaris software). Scale = 100 µm.
Figure 3. C. acnes biofilms after osteoblast-like internalization (a) Biofilm structure of commensal C. acnes strains in dynamic model; (b) volume of biofilm biomass with repartition of Syto9 and PI staining; (c) repartition of Syto9 and PI staining in percentage (Acquisition of images by fluorescent microscopy of two joined fields of one sample and calculation by Imaris software). Scale = 100 µm.
Microorganisms 09 02035 g003
Figure 4. C. acnes biofilms of BPI strains in dynamic model. (a) Biofilm structure of commensal C. acnes strains marked with Syto9 (green) and PI (red) fluochromes; (b) volume of biofilm biomass with repartition of Syto9 and PI staining; (c) repartition of Syto9 and PI staining in percentage (Acquisition of images by fluorescent microscopy of two joined fields of one sample and calculation by Imaris software). Scale = 100 µm.
Figure 4. C. acnes biofilms of BPI strains in dynamic model. (a) Biofilm structure of commensal C. acnes strains marked with Syto9 (green) and PI (red) fluochromes; (b) volume of biofilm biomass with repartition of Syto9 and PI staining; (c) repartition of Syto9 and PI staining in percentage (Acquisition of images by fluorescent microscopy of two joined fields of one sample and calculation by Imaris software). Scale = 100 µm.
Microorganisms 09 02035 g004
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Varin-Simon, J.; Lamret, F.; Colin, M.; Gangloff, S.C.; Mongaret, C.; Reffuveille, F. Comparison of Two Cutibacterium acnes Biofilm Models. Microorganisms 2021, 9, 2035. https://doi.org/10.3390/microorganisms9102035

AMA Style

Varin-Simon J, Lamret F, Colin M, Gangloff SC, Mongaret C, Reffuveille F. Comparison of Two Cutibacterium acnes Biofilm Models. Microorganisms. 2021; 9(10):2035. https://doi.org/10.3390/microorganisms9102035

Chicago/Turabian Style

Varin-Simon, Jennifer, Fabien Lamret, Marius Colin, Sophie C. Gangloff, Céline Mongaret, and Fany Reffuveille. 2021. "Comparison of Two Cutibacterium acnes Biofilm Models" Microorganisms 9, no. 10: 2035. https://doi.org/10.3390/microorganisms9102035

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop